Shuttle Pharmaceuticals Holdings, Inc. insider trading
Every open-market purchase and sale by Shuttle Pharmaceuticals Holdings, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $181,765 6 trades by 1 insider
3 months later: median +23.6% (+20.4% vs S&P 500) Insider sales, 5 years $504,831 5 trades by 1 insider
3 months later: median +24.5% (+20.8% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Shuttle Pharmaceuticals Holdings, Inc.’s insiders pay?
From January 3, 2023 to July 15, 2026, 2 insiders reported 4 open-market purchases and 4 sales not made under a pre-set plan in Shuttle Pharmaceuticals Holdings, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Hrt Financial LP | 10% owner | 4 | — | — | 3 | — | July 15, 2026 |
| Dritschilo Anatoly | CEO and Chairman | 0 | — | — | 1 | — | January 3, 2023 |
← Back to Shuttle Pharmaceuticals Holdings, Inc. · Funds · Politicians